Cheelcare Fiscal Q1 Loss Narrows as Revenue Almost Doubles

10:41 AM EDT, 09/25/2026 (MT Newswires) -- Cheelcare (CHER.V) said Friday that its fiscal first-quarter net loss narrowed to CA$0.02 per share, from CA$0.15 per share, in the prior year period. Revenue for the quarter ended July 31, jumped 98% to CA$828,516, the disability equipment supplier said. Cheelcare's Companion, which is a power add-on device for wheelchairs, became eligible for Medicare and Medicaid reimbursement last January, a statement noted. "Q1 is the first full quarter where we are beginning to see the commercial impact of Companion's Medicare and Medicaid reimbursement eligibility in the United States, which was received in January 2026," said Eugene Cherny, Cheelcare chief executive officer. "That expanded access, together with the growth of our dealer and clinician network, is creating more opportunities to put Companion in the hands of users who can benefit from it.," he added. Cheelcare shares were unchanged at CA$1.49, on the TSX Venture Exchange.